Sulfated alginate microspheres associate with factor H and dampen the inflammatory cytokine response
- 1 September 2016
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 42, 180-188
Abstract
No abstract availableKeywords
Funding Information
- Norwegian Research Council (221576)
- Liaison Committee between the Central Norway Regional Health Authority (46056819)
This publication has 43 references indexed in Scilit:
- Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulationAdvanced Drug Delivery Reviews, 2014
- Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patientDiabetologia, 2013
- Poly-cation containing alginate microcapsules induce cytokines by a complement-dependent mechanismImmunobiology, 2012
- Safety and Viability of Microencapsulated Human Islets Transplanted Into Diabetic HumansDiabetes Care, 2009
- Structure of complement fragment C3b–factor H and implications for host protection by complement regulatorsNature Immunology, 2009
- Foreign body reaction to biomaterialsSeminars in Immunology, 2008
- Translational Mini-Review Series on Complement Factor H: Genetics and disease associations of human complement factor HClinical and Experimental Immunology, 2007
- Microcapsules made by enzymatically tailored alginateJournal of Biomedical Materials Research Part A, 2003
- Regulation of Alternative Pathway Complement Activation by Glycosaminoglycans: Specificity of the Polyanion Binding Site on Factor HBiochemical and Biophysical Research Communications, 1994
- Alginate as immobilization matrix for cellsTrends in Biotechnology, 1990